which are thought to be the end product of intracellular nitroimidazo

This suggested that the region downstream of the CWCV motif provides Dasatinib stability to the IGFBP 2/IGF 1 complex, accounting for l duration IGFBP 2 as compared to IGFBP 248. Self-assembly of IGFBP 2 truncation mutants into nanotubular components To help comprehend the structural basis of the above observation, IGFBP 289 was afflicted by structural analysis using NMR spectroscopy. The polypeptide fragment utilized in our study had an additional cysteine at position 281, as the indigenous type of IGFBP 289 has two cysteines. Under reducing conditions such as in the existence of 1 mM B mercaptoethanol the protein remained a monomer. Nevertheless, upon treatment of T mercaptoethanol by ultrafiltration, it had been found to spontaneously selfassemble into nanotubular structures several micrometers long. This is investigated in depth using transmission electron microscopy, NMR and fluorescence microscopy and found to be the result of inter-molecular disulfide Metastatic carcinoma bonds shaped due to the presence of an unusual number of cysteines in the polypeptide fragment. This statement opens up ways for novel biomedical applications and at the same time frame raises some important questions. For instance, is it possible that polypeptides resulting from proteolysis of IGFBPs also undergo such ordered region if they get an unusual amount of cysteines? Can IGFs play any role in stabilizing or p stabilizing such aggregates influencing, subsequently, the efficiency of proteolysis? There are various instances where the IGFBP fragments resulting from proteolysis contain an odd variety of cysteine residues. The structural attributes of such IGFBP pieces remain Decitabine to be investigated. A possible application of the nanotubes described above lies in targeting integrin positive cancers, benefiting from the fact that IGFBP 289 contains an RGD motif, known to be recognized by 5B1 integrin. In recent years, highly efficient tumor targeting systems-based on carbon nanotubes have been offered. In these programs, soluble carbon nanotubes were functionalized by having an RGD peptide in order to target cell surface integrins. The presence of nanotubes in vivo is probed using Raman imaging. The IGFBP 289 nanotubes we have described could be similarly used and their natural tyrosine fluorescence exploited for detection or tracking. Work in this direction happens to be in progress in our laboratories. IGF antagonist based cancer therapeutics A few peptides have been created which simulate the IGF binding site of IGFBPs. One of these peptides blocked IGF 1 stimulated insulin receptor autophosphorylation. That peptide had a composition like the IGF binding domain of IGFBP 5. Further improvements can take advantage of structural information on the way the N and the C terminal domains of IGFBPs together join IGF thus allowing the usage of combinatorial and rational protein engineering strategies.